GREGORY D PERRY Insider Trading $ACTC Ocata Therapeutics, Inc.
Get free email notifications about insider trading for GREGORY D PERRY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY D PERRY. GREGORY D PERRY is See Remarks in QLT INC/BC ($QLTI) and Sr. VP & CFO in TRANSKARYOTIC THERAPIES INC ($TKTX) and VP, Finance & CEO in TRANSKARYOTIC THERAPIES INC ($TKTX) and VP, Finance and CFO in TRANSKARYOTIC THERAPIES INC ($TKTX) and Director in Ocata Therapeutics, Inc. ($ACTC) and in Aegerion Pharmaceuticals, Inc. ($AEGR) and Chief Financial Officer in Aegerion Pharmaceuticals, Inc. ($AEGR) and See Remarks in Aegerion Pharmaceuticals, Inc. ($AEGR) and in Kala Pharmaceuticals, Inc. ($KALA) and Director in Kala Pharmaceuticals, Inc. ($KALA) and Chief Financial and Business in Eleven Biotherapeutics, Inc. ($EBIO) and Chief Financial Officer in Finch Therapeutics Group, Inc. ($FNCH).
GREGORY D PERRY in Ocata Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY D PERRY: Director
Holdings: 0 shares
Latest Transaction: Feb 11 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GREGORY D PERRY in Ocata Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AEGR, FNCH, KALA, NVLN, ACTC, SESN, TKTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 8.36 | 5,000 | 41,800 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 6.39 | 5,000 | 31,950 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 6.17 | 5,000 | 30,850 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 5.79 | 5,000 | 28,950 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 9.00 | 5,000 | 45,000 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 10.37 | 417 | 4,324 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Sell | U | 8.50 | 21,417 | 182,045 | 0 | 21.4 K to 0 (-100.00 %) |
| Jan 04 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | A | 8.36 | 5,000 | 41,800 | 5,000 | |
| Jan 04 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Grant | A | 0.00 | 1,250 | 0 | 21,417 | 20.2 K to 21.4 K (+6.20 %) |
| Oct 01 2015 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Grant | A | 0.00 | 1,250 | 0 | 20,167 | 18.9 K to 20.2 K (+6.61 %) |
| Jul 02 2015 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Grant | A | 0.00 | 1,250 | 0 | 18,917 | 17.7 K to 18.9 K (+7.08 %) |
| Apr 01 2015 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Grant | A | 0.00 | 1,250 | 0 | 17,667 | 16.4 K to 17.7 K (+7.61 %) |
Page: 1